Johnson & Johnson Applies For Emergency Use Authorization For COVID-19 Vaccine

A dose of the Pfizer COVID-19 vaccine in New York, 2020. Johnson & Johnson is the third vaccine candidate to apply for emergency use authorization from the FDA. The vaccine requires a single dose and doesn

The company’s vaccine has shown to be 85% effective against severe forms of the disease. Patients will only need to receive one shot instead of two, as with other vaccines already in use in the U.S.

(Image credit: Mary Altaffer/AP)

You May Also Like